These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 11094651)

  • 1. Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization.
    Koran LM; Leventhal JL; Fireman B; Jacobson A
    Am J Health Syst Pharm; 2000 Nov; 57(21):1972-8. PubMed ID: 11094651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequacy of pharmacotherapy among medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder.
    Hankin CS; Koran LM; Bronstone A; Black DW; Sheehan DV; Hollander E; Dunn JD; Culpepper L; Knispel J; Dougherty DD; Wang Z
    CNS Spectr; 2009 Dec; 14(12):695-703. PubMed ID: 20394177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram in the treatment of obsessive-compulsive disorder: a double blind placebo control trial.
    Khan MN; Hotiana UA; Ahmad S
    J Ayub Med Coll Abbottabad; 2007; 19(4):58-63. PubMed ID: 18693600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization.
    Fireman B; Koran LM; Leventhal JL; Jacobson A
    Am J Psychiatry; 2001 Nov; 158(11):1904-10. PubMed ID: 11691699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Price LH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
    Zak JP; Miller JA; Sheehan DV; Fanous BS
    J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of childhood obsessive-compulsive disorder.
    Leonard HL; Rapoport JL
    Psychiatr Clin North Am; 1989 Dec; 12(4):963-70. PubMed ID: 2690035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive-coping therapy for obsessive-compulsive disorder: a randomized controlled trial.
    Ma JD; Wang CH; Li HF; Zhang XL; Zhang YL; Hou YH; Liu XH; Hu XZ
    J Psychiatr Res; 2013 Nov; 47(11):1785-90. PubMed ID: 23988179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoepidemiology of obsessive-compulsive disorder: A Swedish nationwide cohort study.
    Isomura K; Nordsletten AE; Rück C; Ljung R; Ivarsson T; Larsson H; Mataix-Cols D
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):693-704. PubMed ID: 26922101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.
    Cheer SM; Figgitt DP
    Paediatr Drugs; 2001; 3(10):763-81. PubMed ID: 11706925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obsessive-compulsive disorder in children and adolescents].
    Rotberg B; Zalsman G; Weizman A
    Harefuah; 2008 Apr; 147(4):324-9, 374, 373. PubMed ID: 18686815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limbic system surgery for treatment-refractory obsessive-compulsive disorder: a prospective long-term follow-up of 64 patients.
    Sheth SA; Neal J; Tangherlini F; Mian MK; Gentil A; Cosgrove GR; Eskandar EN; Dougherty DD
    J Neurosurg; 2013 Mar; 118(3):491-7. PubMed ID: 23240700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.
    Anagnostopoulos DC; Korlou S; Sakellariou K; Kondyli V; Sarafidou J; Tsakanikos E; Giannakopoulos G; Liakopoulou M
    Psychiatriki; 2016; 27(1):27-36. PubMed ID: 27110880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.
    Rufer M; Hand I; Alsleben H; Braatz A; Ortmann J; Katenkamp B; Fricke S; Peter H
    Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):121-8. PubMed ID: 15812606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term experience with citalopram in the treatment of adolescent OCD.
    Thomsen PH; Ebbesen C; Persson C
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):895-902. PubMed ID: 11501688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram treatment of children and adolescents with obsessive-compulsive disorder: a preliminary report.
    Mukaddes NM; Abali O; Kaynak N
    Psychiatry Clin Neurosci; 2003 Aug; 57(4):405-8. PubMed ID: 12839522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inadequate pharmacotherapy in patients with obsessive-compulsive disorder].
    Denys D; van Megen HJ; Westenberg HG
    Ned Tijdschr Geneeskd; 2001 May; 145(19):914-8. PubMed ID: 11387867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pica and the obsessive-compulsive spectrum disorders.
    Stein DJ; Bouwer C; van Heerden B
    S Afr Med J; 1996 Dec; 86(12 Suppl):1586-8, 1591-2. PubMed ID: 9180801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation antipsychotics for obsessive compulsive disorder.
    Komossa K; Depping AM; Meyer M; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008141. PubMed ID: 21154394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.